The detection of antibodies to recombinant interferon alfa-2a in human serum.

[1]  R. Spiegel,et al.  Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A). , 1986, The American journal of medicine.

[2]  J. Quesada,et al.  Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. K. Kelsey,et al.  A radioimmunologic technique to screen for antibodies to α-2 interferon , 1984 .

[4]  F. Real,et al.  Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. , 1983, The New England journal of medicine.

[5]  T. Merigan,et al.  Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. , 1982, Annals of internal medicine.

[6]  S. Pestka,et al.  Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. , 1981, The Journal of biological chemistry.

[7]  S. Pestka,et al.  Production of hybridomas secreting monoclonal antibodies to the human leukocyte interferons. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. A. Havell.  [72] Production and quantitation of neutralizing antibodies for human fibroblast interferon , 1981 .

[9]  S. Pestka,et al.  Definition and classification of the interferons. , 1981, Methods in enzymology.

[10]  S. Colowick,et al.  Methods in Enzymology , Vol , 1966 .